Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | MMP3 | P08254 | 1/20 | 0.61 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.58 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.58 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.58 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.58 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | KIF11 | P52732 | 2/20 | 0.54 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28680466 | 1.00 | TSHR (0.68) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Water SCHEMBL27280762 | 1.00 | TSHR (0.68) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Water SCHEMBL27280164 | 1.00 | TSHR (0.68) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| SCHEMBL72569 | 1.00 | TSHR (0.68) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Water SCHEMBL6336152 | 1.00 | TSHR (0.68) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Hydrochloric Acid SCHEMBL4599950 | 0.97 | TSHR (0.65) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| SCHEMBL28503971 | 0.97 | TSHR (0.65) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Hydrochloric Acid SCHEMBL2338378 | 0.97 | TSHR (0.65) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| Cyanide SCHEMBL28220142 | 0.95 | TSHR (0.62) | TSHRMMP3CYP11B2GABRA1GABRG2 | |
| SCHEMBL13682562 | 0.93 | TSHR (0.59) | TSHRMMP3CYP11B2GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271580-A | Anion exchange membrane prepared from aryl piperidine copolymer containing triazine ring branched structure, preparation method and application | 大连理工大学 | 2024-07-02 | — | — | CN | claimed |
| CN-118271580-B | Anion exchange membrane prepared from aryl piperidine copolymer containing triazine ring branched structure, preparation method and application | 大连理工大学 | 2024-08-16 | — | — | CN | disclosed |
| CN-118271580-A | Anion exchange membrane prepared from aryl piperidine copolymer containing triazine ring branched structure, preparation method and application | 大连理工大学 | 2024-07-02 | — | — | CN | disclosed |
| US-20230399567-A1 | Liquid Crystal Element and Emulsion Composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| WO-2023150908-A1 | LIQUID CRYSTAL COMPOSITION AND PREPARATION METHOD THEREFOR, AND DISPLAY PANEL | 京东方科技集团股份有限公司 | 2023-08-17 | — | — | WO | disclosed |
| EP-3802730-B1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-04-19 | — | — | EP | disclosed |
| CN-108603121-B | Liquid crystal medium and high-frequency module containing same | 默克专利股份有限公司 | 2023-02-10 | — | — | CN | disclosed |
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2022-09-13 | — | — | US | disclosed |
| US-20220146922-A1 | TRANSMISSIVE SCREEN AND VIDEO IMAGE DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11186773-B2 | Liquid crystal compositions, mixtures, elements, and dimmable devices | NITTO DENKO CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| US-7507830-B2 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | PHARMACORE, INC. (US) | 2009-03-24 | — | — | US | disclosed |
| CN-100410236-C | Substituted methylene amide derivatives as protein tyrosine phosphatase modulators | APPLIED RESEARCH SYSTEMS (CH) | 2008-08-13 | — | — | CN | disclosed |
| US-7311897-B2 | Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-7311897-B2 | Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-6962999-B2 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | PHARMACORE, INC. (US) | 2005-11-08 | — | — | US | disclosed |
| CN-1633410-A | Substituted methylene amide derivatives as protein tyrosine phosphatase modulators | APPLIED RESEARCH SYSTEMS (AN) | 2005-06-29 | — | — | CN | disclosed |
| US-20050124808-A1 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | DSM I.P. ASSETS B.V. (NL) | 2005-06-09 | — | — | US | disclosed |
| US-20030100760-A1 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | DSM N.V. (NL) | 2003-05-29 | — | — | US | disclosed |
| EP-1279656-A2 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | DSM N.V. (NL) | 2003-01-29 | — | — | EP | disclosed |
| US-4673529-A | LIQUID CRYSTALS JLMOKOUM INTEGRATED CIRCUITS | CHISSO CORPORATION (JP) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, ALDH1A2, CYBA | TSHR 4747/4885MMP3 3661/4885CYP11B2 272/4885 |
| US-20030100760-A1 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | AHR, PAH, DDT | TSHR 2211/4885MMP3 4842/4885CYP11B2 731/4885 |
| US-20050124808-A1 | Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles | AHR, PAH, DDT | TSHR 2211/4885MMP3 4842/4885CYP11B2 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.